The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Glucocorticoids Act Directly on Osteoblasts and Osteocytes to Induce Their Apoptosis and Reduce Bone Formation and Strength
Abstract
Whether the negative impact of excess glucocorticoids on the skeleton is due to direct effects on bone cells, indirect effects on extraskeletal tissues, or both is unknown. To determine the contribution of direct effects of glucocorticoids on osteoblastic/osteocytic cells in vivo, we blocked glucocorticoid action on these cells via transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2, an enzyme that inactivates glucocorticoids. Osteoblast/osteocyte-specific expression was achieved by insertion of the 11beta-hydroxysteroid dehydrogenase type 2 cDNA downstream from the osteoblast-specific osteocalcin promoter. The transgene did not affect normal bone development or turnover as demonstrated by identical bone density, strength, and histomorphometry in adult transgenic and wild-type animals. Administration of excess glucocorticoids induced equivalent bone loss in wild-type and transgenic mice. As expected, cancellous osteoclasts were unaffected by the transgene. However, the increase in osteoblast apoptosis that occurred in wild-type mice was prevented in transgenic mice. Consistent with this, osteoblasts, osteoid area, and bone formation rate were significantly higher in glucocorticoid-treated transgenic mice compared with glucocorticoid-treated wild-type mice. Glucocorticoid-induced osteocyte apoptosis was also prevented in transgenic mice. Strikingly, the loss of vertebral compression strength observed in glucocorticoid-treated wild-type mice was prevented in the transgenic mice, despite equivalent bone loss. These results demonstrate for the first time that excess glucocorticoids directly affect bone forming cells in vivo. Furthermore, our results suggest that glucocorticoid-induced loss of bone strength results in part from increased death of osteocytes, independent of bone loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 5×
“, Decatur, GA) as previously described (3, 4, 15).”
BackgroundMethodResultInfluentialSelf-citationUse of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
Nontraumatic Necrosis of Bone (Osteonecrosis)
Desforges, J. F., & Mankin, H. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262206 · Cited by 958
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · cited 5×
“We have previously demonstrated that use of trypan blue exclusion to quantitate the apoptosis of MLO-Y4 cells induced by these agents yielded levels of apoptosis similar to those detected by other methods such as nuclear morphology and caspase 3 activation (6).”
BackgroundMethodInfluentialSelf-citationHofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794
Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559
Establishment of an osteocyte-like cell line, MLO-Y4
Kato, Y., Windle, J. J., Koop, B. A., Mundy, G. R., & Bonewald, L. F. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.12.2014 · Cited by 500
Heterologous introns can enhance expression of transgenes in mice.
Palmiter, R. D., Sandgren, E. P., Avarbock, M. R., Allen, D. D., & Brinster, R. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.478 · Cited by 484
Reversal of Bone Loss in Mice by Nongenotropic Signaling of Sex Steroids
Kousteni, S., Chen, J.-R., Bellido, T., Han, L., Ali, A. A., O'Brien, C. A., Plotkin, L., Fu, Q., Mancino, A. T., Wen, Y., et al. (2002) · Science · doi:10.1126/science.1074935 · Cited by 420
Self-citationMechanisms of Glucocorticoid Action in Bone
CANALIS, E., & DELANY, A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04204.x · Cited by 406
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo.
Lacey, D. L., Tan, H. L., Lu, J., Kaufman, S., Van, G., Qiu, W., Rattan, A., Scully, S., Fletcher, F., Juan, T., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64556-7 · Cited by 391
Bone loss in response to long-term glucocorticoid therapy
LoCascio, V., Bonucci, E., Imbimbo, B., Ballanti, P., Adami, S., Milani, S., Tartarotti, D., & DellaRocca, C. (1990) · Bone and Mineral · doi:10.1016/0169-6009(91)90139-q · Cited by 384
Peel, N. F., Moore, D. J., Barrington, N. A., Bax, D. E., & Eastell, R. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.10.801 · Cited by 379
Apoptosis of Osteocytes in Glucocorticoid-Induced Osteonecrosis of the Hip1
Weinstein, R. S., Nicholas, R. W., & Manolagas, S. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6714 · Cited by 378
Self-citationGrignani, F., Kinsella, T. J., Mencarelli, A., Valtieri, M., Riganelli, D., Grignani, F., Lanfrancone, L., Peschle, C., Nolan, G. P., & Pelicci, P. G. (1998) · PubMed · Cited by 349
Jilka, R. L., Weinstein, R. S., Takahashi, K., Parfitt, A. M., & Manolagas, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118600 · Cited by 339
Self-citationWeinstein, R. S., Chen, J.-R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214538 · Cited by 313
Self-citationO'Brien, C. A., Gubrij, I., Lin, S.-C., Saylors, R. L., & Manolagas, S. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19301 · Cited by 313
Self-citationVertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.
Luengo, M., Picado, C., Del Rio, L., Guanabens, N., Montserrat, J. M., & Setoain, J. (1991) · Thorax · doi:10.1136/thx.46.11.803 · Cited by 241
Risk of vertebral fracture in women with rheumatoid arthritis.
Spector, T. D., Hall, G. M., McCloskey, E. V., & Kanis, J. A. (1993) · BMJ · doi:10.1136/bmj.306.6877.558 · Cited by 230
Glucocorticoid-Induced Osteoporosis
Weinstein, R. S. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010007108155 · Cited by 189
Self-citationCol1a1-Driven Transgenic Markers of Osteoblast Lineage Progression
Dacic, S., Kalajzić, I., Višnjić, D., Lichtler, A., & Rowe, D. W. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.7.1228 · Cited by 146
Corticosteroids and Fractures: A Close Encounter of the Third Cell Kind
Manolagas, S. C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1001 · Cited by 138
Self-citationGregorio, G. B. D., Yamamoto, M., Ali, A., Abe, E., Roberson, P. K., Manolagas, S. C., & Jilka, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11653 · Cited by 127
Self-citationSher, L. B., Woitge, H. W., Adams, D. J., Gronowicz, G., Krozowski, Z. S., Harrison, J. R., & Kream, B. E. (2003) · Endocrinology · doi:10.1210/en.2003-0655 · Cited by 124
Functional Hierarchy between Two OSE2 Elements in the Control of Osteocalcin Gene Expression in Vivo
Frendo, J., Xiao, G., Fuchs, S., Franceschi, R. T., Karsenty, G., & Ducy, P. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30509 · Cited by 114
Corticosteroids Do Not Alter the Threshold for Vertebral Fracture
Selby, P. L., Halsey, J. P., Adams, K., Klimiuk, P. S., Knight, S. M., Pal, B., Stewart, I. M. G., & Swinson, D. R. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.5.952 · Cited by 92
The Skeletal Effects of Glucocorticoid Excess Override Those of Orchidectomy in Mice
Weinstein, R. S., Jia, D., Powers, C. C., Stewart, S. A., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2004) · Endocrinology · doi:10.1210/en.2003-1133 · Cited by 86
Self-citationImmunocytochemical demonstration of extracellular matrix proteins in isolated osteocytes
Aarden, E. M., Wassenaar, A. M., Alblas, M. J., & Nijweide, P. J. (1996) · Histochemistry and Cell Biology · doi:10.1007/bf02473312 · Cited by 78
Immunolocalization of NAD-dependent 11β-hydroxysteroid dehydrogenase in human kidney and colon
Kyossev, Z. N., Walker, P. D., & Reeves, W. B. (1996) · Kidney International · doi:10.1038/ki.1996.39 · Cited by 75
Carvajal, C. A., González, A. A., Romero, D. G., González, Á., Mosso, L. M., Lagos, E., Hevia, M. D. P., Rosati, M. P., Pérez‐Acle, T., Gómez-Sánchez, C. E., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021909 · Cited by 57
Clinical and Basic Aspects of Glucocorticoid Action in Bone
Kream, B. E., Graves, L., & Lukert, B. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00061-6 · Cited by 47
Evans, S. F., & Davie, M. W. J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.4.269 · Cited by 39
Cited by
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Manolagas, S. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0024 · Cited by 1,200
Self-citationGlucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
The Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Metadata
- Authors
- O’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2004-04
- Volume
- 145
- Issue
- 4
- Pages
- 1835-1841
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2116751183
- Cited by
- 771
- References
- 33
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.